Status:
UNKNOWN
Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer
Lead Sponsor:
Centre Hospitalier Departemental Vendee
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The 2014-2019 cancer plan emphasizes the need to "reduce the impact of cancer on personal life". The impact of cancer on sexuality is multifactorial: fatigue, anxiety, impaired body image, chemothera...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years
- Female gender
- Histologically proven non-metastatic breast cancer
- Indication of adjuvant hormone therapy
- Patient able to understand a newsletter and to agree to participate
Exclusion
- Age under 18 years
- Pregnant woman
- Adjuvant chemotherapy
- Patient followed for heavy psychiatric pathology (requiring guardianship or trusteeship)
- Persons protected or deprived of their liberty
- Male
Key Trial Info
Start Date :
February 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03395327
Start Date
February 20 2018
End Date
May 15 2020
Last Update
March 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHD Vendée
La Roche-sur-Yon, France, 85925